Lifesciences
Increased demand for improved healthcare is driving the lifesciences industry to find solutions for tomorrow, allowing the development of ground-breaking technologies. This is against a backdrop of significant challenges including reductions in funding, increased competition from generic manufacturing, ever tighter regulatory controls and investor scrutiny.
Our integrated Lifesciences team combines its legal skills, experience and knowledge of the industry to provide relevant and practical advice and solutions.
Clients include university spin-outs, biotechs, investors, bioinformatics, medical device companies, pharmaceutical companies, distributors of branded and generic drugs and medicines, and other organisations within the lifesciences industry.
Berryman is a corporate partner at BioCity and Medilink East Midlands.
